0001209191-20-045135.txt : 20200805
0001209191-20-045135.hdr.sgml : 20200805
20200805164100
ACCESSION NUMBER: 0001209191-20-045135
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200805
DATE AS OF CHANGE: 20200805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bright Rex
CENTRAL INDEX KEY: 0001327501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 201078210
MAIL ADDRESS:
STREET 1: 5641 LAKE VISTA DRIVE
CITY: BONSALL
STATE: CA
ZIP: 92003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Menlo Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-03
0
0001566044
Menlo Therapeutics Inc.
MNLO
0001327501
Bright Rex
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER
NJ
08807
1
0
0
0
Stock Options
1.72
2020-08-03
4
A
0
22500
0.00
A
2030-08-03
Common Stock
22500
22500
D
These options vest over a 12 month period in equal, quarterly installments, ending August 3, 2021.
/s/ Mutya Harsch, attorney-in-fact for Rex Bright
2020-08-05